Greg Pyszczymuka is Chief Commercial Officer of AYTU BIOPHARMA, INC. Currently has a direct ownership of 22,976 shares of AYTU, which is worth approximately $54,912. The most recent transaction as insider was on Jun 30, 2024, when has been sold 208 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23K
0.91% 3M change
3.76% 12M change
Total Value Held $54,912

GREG PYSZCZYMUKA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2024
BUY
Exercise of conversion of derivative security
-
208 Added 0.9%
22,976 Common Shares
Mar 31 2024
BUY
Exercise of conversion of derivative security
-
208 Added 0.91%
22,768 Common Shares
Dec 31 2023
BUY
Exercise of conversion of derivative security
-
209 Added 0.92%
22,560 Common Shares
Sep 30 2023
BUY
Exercise of conversion of derivative security
-
208 Added 0.92%
22,351 Common Shares
Jun 30 2023
BUY
Exercise of conversion of derivative security
-
208 Added 0.93%
22,143 Common Shares
Jun 16 2023
BUY
Open market or private purchase
$22,440 $1.87 p/Share
12,000 Added 35.36%
21,935 Common Shares
Apr 25 2023
BUY
Exercise of conversion of derivative security
-
833 Added 7.74%
9,935 Common Shares
Dec 19 2022
BUY
Open market or private purchase
$24,000 $0.24 p/Share
100,000 Added 35.45%
182,056 Common Stock
GP

Greg Pyszczymuka

Chief Commercial Officer
Englewood, CO

Track Institutional and Insider Activities on AYTU

Follow AYTU BIOPHARMA, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AYTU shares.

Notify only if

Insider Trading

Get notified when an Aytu Biopharma, Inc insider buys or sells AYTU shares.

Notify only if

News

Receive news related to AYTU BIOPHARMA, INC

Track Activities on AYTU